InDex Pharmaceuticals utvecklar cobitolimod, ett nytt läkemedel för "Redeye reiterates its positive stance on InDex Pharmaceuticals following the release of

Köp aktien InDex Pharmaceuticals Holding AB (INDEX). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid

Klicka här för att följa aktiekursen i realtid InDex Pharmaceuticals VD Peter Zerhouni presenterar på Investor Forum 1 juni. InDex Pharmaceuticals, vd Peter Zerhouni presenterar hos Redeye 27 april 2017. 0 87 0. 2019-11-19 · InDex Pharmaceuticals Presents at Redeye Life Science Day and Avanza Börsdag November 19, 2019 News provided by. Index Pharmaceuticals Nov 18, 2019, 02:21 ET. Share this article. 2019-11-19 · STOCKHOLM, Nov. 18, 2019 /PRNewswire/ --November 18, 2019 - InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at ROOTS@Downtown Camper by Scandic, Drottninggatan 28 in Stockholm at 08:35 CET and at Avanza Börsdag at Operaterrassen, Karl XII:s torg in Stockholm at 11:15 CET on November 19. 2019-11-19 · STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- November 18, 2019 - InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- November 18, 2019 - InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at ROOTS@Downtown Camper by Scandic, Drottninggatan 28 in Stockholm at 08:35 CET and at Avanza Börsdag at Operaterrassen, Karl XII:s torg in Stockholm at 11:15 CET on November 19.

May 26, 2020 – InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Growth Day 2020 on June 2 at 15.50 CET. The presentation will be livestreamed and can be followed at https://www.redeye.se/live/growth-day-2020. InDex Pharmaceuticals presents at Redeye Life Science Day 2020 24 November 2020 - Other press release November 24, 2020 – InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at 13:50 CET on November 26. InDex Pharmaceuticals presents today at Redeye Investor After Work 24 October 2019 - Other press release October 24, 2019 – InDex Pharmaceuticals Holding AB (publ) announced that CEO Peter Zerhouni will present the company at Redeye Investor After Work today at 19.30 CET at Scandic Rubinen, Kungsportsavenyen 24, in Gothenburg. InDex Pharmaceuticals: Huvudresultat från CONDUCT i slutet av augusti Redeye Research Note • Published 15 August 2019 Top Picks: Säljer två “special situations” InDex Pharmaceuticals presents at Redeye Growth Day 2020 Tue, May 26, 2020 08:00 CET. May 26, 2020 – InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Growth Day 2020 on June 2 at 15.50 CET. November 24, 2020 - InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at 13:50 CET on November 26. InDex Pharmaceuticals in brief InDex is a pharmaceutical development company focusing on immunological diseases where there is a high unmet medical need for new treatment options. The company’s lead asset is the drug candidate cobitolimod, which is in late stage clinical development for the treatment of moderate to severe ulcerative colitis InDex Pharmaceuticals presents today at Redeye Investor After Work Thu, Oct 24, 2019 08:01 CET. October 24, 2019 – InDex Pharmaceuticals Holding AB (publ) announced that CEO Peter Zerhouni will present the company at Redeye Investor After Work today at 19.30 CET at Scandic Rubinen, Kungsportsavenyen 24, in Gothenburg. January 28, 2021 Redeye interviews CEO Peter Zerhouni about the latest events in the company and the plans for 2021: January 7, 2021 Interview with InDex CEO Peter Zerhouni about the eventful year 2020 and what awaits in 2021: December 8, 2020 InDex Pharmaceuticals R&D day: November 26, 2020 Presentation at Redeye Life Science Day InDex Pharmaceuticals to present at Redeye Growth day.

InDex Pharmaceuticals, vd Peter Zerhouni presenterar hos Redeye 27 april 2017 29:34 InDex Pharmaceuticals, vd Peter Zerhouni presenterar på Småbolagsdagen 12 juni

2019-11-19 · STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at ROOTS@Downtown Köp aktien InDex Pharmaceuticals Holding AB (INDEX). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid InDex Pharmaceuticals VD Peter Zerhouni presenterar på Investor Forum 1 juni. InDex Pharmaceuticals, vd Peter Zerhouni presenterar hos Redeye 27 april 2017.

8 dec 2020 InDex is a pharmaceutical development company focusing on Redeye AB with e-mail certifiedadviser@redeye.seand phone number +46 8

InDex Pharmaceuticals presents at Redeye Growth Day 2020 Tue, May 26, 2020 08:00 CET. May 26, 2020 – InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Growth Day 2020 on June 2 at 15.50 CET. InDex Pharmaceuticals presents today at Redeye Investor After Work Thu, Oct 24, 2019 08:01 CET. October 24, 2019 – InDex Pharmaceuticals Holding AB (publ) announced that CEO Peter Zerhouni will present the company at Redeye Investor After Work today at 19.30 CET at Scandic Rubinen, Kungsportsavenyen 24, in Gothenburg. November 24, 2020 – InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at 13:50 InDex Pharmaceuticals presenterar på Redeye Growth Day, 10 juni 2019 3 juni 2019 - Övrigt pressmeddelande 3 juni 2019 – InDex Pharmaceuticals Holding AB (publ) meddelar idag att VD Peter Zerhouni kommer att presentera den senaste utvecklingen i bolaget på Redeye Growth Day på Haymarket by Scandic, Hötorget 13-15, i Stockholm den 10 juni, kl. 14.40. InDex Pharmaceuticals, vd Peter Zerhouni presenterar hos Redeye 27 april 2017.

2019-06-10 November 24, 2020 – InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at 13:50 Redeye: InDex Pharmaceuticals - Vid ett vägskäl mån, sep 30, 2019 07:42 CET. En månad har gått sedan InDex Pharmaceuticals presenterade data från deras fas IIb studie CONDUCT, vi ger vår syn på framtiden för caset och vilka alternativa vägar som finns framåt. 2019-11-19 26 maj 2020 – InDex Pharmaceuticals Holding AB (publ) meddelar idag att VD Peter Zerhouni kommer att presentera bolaget på Redeye Growth Day 2020 den 2 juni, kl Index Pharmaceuticals has managed to publish on the mechanism of action, which makes it easier to negotiate deals and the FDA/EMA also like this, and easier to affect the practitioners.
Change valorant password

2021-04-07 · STOCKHOLM, April 7, 2021 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that a patent covering 19 compounds from the company's DIMS platform has been granted by the InDex Pharmaceuticals Holding AB (publ) year-end report 2020 Financing secured for phase III development of cobitolimod “With the equity financing secured news.cision.com Redeye AB agerar finansiell rådgivare till Annexin Pharmaceuticals i samband med att bolaget genomför en IPO inför planerad listning på Nasdaq First North.

InDex Pharmaceuticals presents at Redeye Life Science Day 2020. InDex Pharmaceuticals: Huvudresultat från CONDUCT i slutet av augusti Redeye Research Note • Published 15 August 2019 Top Picks: Säljer två “special situations” 26 maj 2020 – InDex Pharmaceuticals Holding AB (publ) meddelar idag att VD Peter Zerhouni kommer att presentera bolaget på Redeye Growth Day 2020 den 2 juni, kl.
Scandic analys

InDex Pharmaceuticals InDex Pharmaceuticals updates shareholders list. InDex Pharmaceuticals Holding AB (publ) today announced that the list of shareholders has been updated on the homepage with information as of August 30, 2019.

For more information, please visit www.indexpharma.com. InDex Pharmaceuticals in brief InDex is a pharmaceutical development company focusing on immunological diseases where there is a high unmet medical need for new treatment options. InDex Pharmaceuticals InDex Pharmaceuticals updates shareholders list.

Stephanie blake mary kay

InDex Pharmaceuticals presents at Redeye Life Science Day 2020. November 24, 2020 – InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni.

June 3, 2019 – InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Growth Day at Haymarket by Sca

InDex Pharmaceuticals: Q4 – Approaching the next step (Redeye) 2021-02-25 10:44. Redeye reiterates its Base case of SEK 4,5 following the release of today's year-end report. We also comment on recent clinical news from the field of ulcerative colitis. November 24, 2020 - InDex Pharmaceuticals Holding AB today announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at 13:50 CET on November 26. The presentation will be | January 31, 2021 24 oktober 2019 – InDex Pharmaceuticals Holding AB (publ) meddelar att VD Peter Zerhouni kommer att presentera bolaget på Redeye Investor After Work idag kl. 19.30 på … InDex Pharmaceuticals Holding Redeye expects positive momentum in InDex shares as the market's focus shifts towards the phase III-study rather than the dilution related to the pending transaction.

The company's shares (ticker INDEX) are traded on Nasdaq First North Growth Market. Redeye AB with Senaste nyheterna om aktien InDex Pharmaceuticals (INDEX).